Top Markets
#1 Bitway Bitway +55.99%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +39.20%
#3 Starpower Starpower +36.58%
#4 Pons Pons +34.90%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.72%
#6 aelf aelf +20.67%
#7 SkyAI SkyAI +19.93%
#8 Ocean Protocol Ocean Protocol +17.12%
#9 Mubarak Mubarak +16.27%
#10 Decred Decred +15.76%
Coin of the day
Bitway Bitway
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rang in Aktien #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Aktienkurs
$0.365
Zuletzt synchronisiert: 2025-08-01
Marktkapitalisierung
$21.54M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Elevation Oncology, Inc. (ELEV)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Elevation Oncology, Inc. (ELEV)
Dividendenrendite (TTM) von Elevation Oncology, Inc. (Aktienkürzel: ELEV) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Elevation Oncology, Inc. (ELEV) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH